08223 ZYY
- 1.700
- +0.040+2.41%
ZYY News
紫元元：2023 年報
Ziyuan Announces 2023 Annual Results Profit attributable to shareholders of 145.63 million yuan, a year-on-year decrease of 7.9%
Ziyuanyuan (08223) announced the results for the year ended December 31, 2023. The group obtained total revenue of RMB 498 million (same unit), an increase of 53.41% year on year; profit attributable to company owners was RMB 145.63 million, a decrease of 7.9% year on year; profit per share was 3.64 points.
Ziyuan Yuan (08223) announced annual results. Profit attributable to shareholders of 145.63 million yuan decreased by 7.9% year-on-year
Ziyuanyuan (08223) announced the results for the year ended December 31, 2023. The group obtained total revenue, people...
ZYY: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Ziyuanyuan Holdings Group Limited's (HKG:8223) 28% Share Price Plunge Could Signal Some Risk
The Ziyuanyuan Holdings Group Limited (HKG:8223) share price has softened a substantial 28% over the previous 30 days, handing back much of the gains the stock has made lately. Longer-term, the sto
What Ziyuanyuan Holdings Group Limited's (HKG:8223) 26% Share Price Gain Is Not Telling You
Ziyuanyuan Holdings Group Limited (HKG:8223) shareholders would be excited to see that the share price has had a great month, posting a 26% gain and recovering from prior weakness. The bad news is
Ziyuanyuan (08223) plans to discount approximately 19.23% and issue 30 million subscription shares to raise about HK$43.5 million net
According to the Zhitong Finance App, Ziyuan (08223) announced that on December 29, 2023, the company plans to issue 15 million subscription shares to Yu Jianping and Zheng Zhihong respectively. The subscription price for each subscribed share is HK$1.47, a discount of about 19.23% from the closing price of HK$1.82 per share. Net funding of approximately HK$43.5 million is intended to be used for general working capital to develop the Group's financial leasing business and medical device and consumables trading business. On the same day, that is, the final end date of the placement agreement, the prerequisites for the placement agreement have not been met, and the proposed transactions under the placement agreement have expired and been terminated
Zi Yuanyuan (08223) discounted about 13%, net value of about HK$42.7 million, did not fall but rose nearly 30%
Jinwu Financial News | Ziyuan Yuan (08223) rose nearly 30% to HK$1.62. The stock closed down 13% on the previous trading day. According to the news, Zi Yuanyuan announced that it will place up to 40 million shares, accounting for about 9.09% of the expanded share capital. The placement price is HK$1.11 per share, a discount of about 13.28% from the closing price of HK$1.28 on the 12th. The total proceeds amount is about HK$44.4 million, a net amount of about HK$42.7 million, of which about 20-30% will cover ongoing administrative and operating expenses, and 70-80% will be used to develop the Group's financial leasing business and medical device and consumables trading business.
Zi Yuanyuan (08223) plans to discount approximately 13.28%, place up to 40 million shares, place up to 40 million shares, net raise about HK$42.7 million
Zi Yuanyuan (08223) issued an announcement. On December 12, 2023, the company signed a placement agreement with the placement agent...
Zi Yuanyuan (08223.HK) plans to further develop medical device and consumables trading business
Gelonghui November 24 | Zi Yuanyuan (08223.HK) announced that on November 24, 2023, the company (“buyer”) signed a memorandum of understanding with He Chao, Shenzhen Yunrui Investment Limited Partnership (Limited Partnership) and Shenzhen Borui Cloud Investment Partnership (“Seller”). According to the MOU, the buyer intended to buy and the seller intended to sell shares of Shenzhen Chuangda Yunrui Intelligent Technology Co., Ltd. (“Target Company”) and the buyer intended to inject capital into the target company. After the shares to be sold and capital injections are completed, the Group intends to own 51% of the target company's shares. The target company is a limited company established in China
ZYY: THIRD QUARTERLY REPORT 2023
ZYY: THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
Zi Yuanyuan (08223.HK) plans to buy Guangdong Dejiang Medical Products Co., Ltd. to develop medical device and consumables trading business
Gelonghui, October 27, Ziyuanyuan (08223.HK) announced that on October 27, 2023, the Company (“Buyer”) signed a Memorandum of Understanding with Hu Yang and Shenzhen Dejiang Investment Co., Ltd. (“Seller”). According to the MOU, the buyer intended to buy and the seller intended to sell shares in Guangdong Dejiang Medical Products Co., Ltd. (“Target Company”). The target company is a limited company established in China, founded in 2017, dedicated to R&D, manufacturing and sales of medical physiotherapy equipment. The founding team of the target company comes from well-known companies in the industry and has many years of work experience in the medical device industry
ZYY: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2022
ZYY: INTERIM REPORT 2023
Ziyuanyuan Announces Interim Results Shareholders' Shareholders' Profit of 6.115 Million Yuan Decreased 24.53% Year on Year
Ziyuanyuan (08223) announced interim results for the six months ended June 30, 2023. The group achieved total revenue of RMB 176 million (same unit), an increase of 23.27% over the previous year; profit due to company owners was 6.115 million yuan, a decrease of 24.53% over the previous year; profit of 1.53 minutes per share.
Ziyuan Yuan (08223.HK)'s interim earnings increased 23.3% to 176 million yuan
On August 11, GLONGHUI | Ziyuan (08223.HK) announced that in the six months ending June 30, 2023, the Group's revenue increased by about 23.3% to about RMB 175.6 million. The total profit and overall revenue attributable to company owners during this period was approximately RMB 6.1 million and RMB 8.1 million, respectively. The decrease in total profit and overall revenue attributable to company owners during this period was mainly due to a decrease in revenue and other net income and loss from the same period in 2022 (i) financial leasing services and maternal and child confinement services; and (ii) increased financing costs, which offset (i) medical devices
ZYY: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Ziyuanyuan (08223) has added an additional guarantee amount of about 106 million yuan in the past year to provide China Construction Bank with customer repayment obligations
According to the Zhitong Finance App, Ziyuanyuan (08223) announced that on August 30, 2022, Ruiheng, a wholly-owned subsidiary of the company, signed a 2022 cooperation agreement with China Construction Bank. China Construction Bank agreed to provide customers with a trade loan of no more than RMB 500 million to purchase dental equipment from Ruiheng. The individual loan term and amount of each trade loan shall not exceed 36 months and RMB 1 million, respectively. The trade loan can only be used to purchase dental medical equipment from Ruiheng. According to the 2022 cooperation agreement, the guarantor shall use China Construction Bank as the beneficiary to execute the guarantee
ZYY: DATE OF BOARD MEETING
Analysis
Price Target
No Data
